Literature DB >> 1583657

Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population.

M E Mennie1, W A Liston, D J Brock.   

Abstract

A questionnaire was given to 180 patients in an antenatal clinic, who were eligible to enter a pilot trial of cystic fibrosis (CF) carrier testing, seeking their views on the information leaflet inviting them to participate; 161 patients (89%) entered the trial and 145 patients (81%) responded to the questionnaire, including 10 who did not enter the trial. Ninety-six percent of these found the leaflet easy to understand, and 97% of those partners who read the leaflet also found it easy to understand. Fifteen percent of patients thought the leaflet should give additional information. Most (92%) had heard of CF before reading the leaflet, television being the most common source of information. Although avoiding the birth of a child with CF was the reason most patients gave for wishing to be screened, almost as many were interested to know their carrier status. The decision to accept or decline testing was taken in conjunction with their partner by 63% of women. Of those who were screened, 59% stated that taking the test made them feel reassured, while 38% felt slightly apprehensive. It was concluded that, with a number of minor amendments, the leaflet met the specific needs of the target patient population.

Entities:  

Mesh:

Year:  1992        PMID: 1583657      PMCID: PMC1015949          DOI: 10.1136/jmg.29.5.308

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  12 in total

Review 1.  Effectiveness and efficacy of antenatal care.

Authors:  P A Field
Journal:  Midwifery       Date:  1990-12       Impact factor: 2.372

2.  The incidence of different cystic fibrosis mutations in the Scottish population: effects on prenatal diagnosis and genetic counselling.

Authors:  A E Shrimpton; I McIntosh; D J Brock
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

3.  Development of a self-administered questionnaire to measure women's knowledge of prenatal screening and diagnostic tests.

Authors:  T M Marteau; M Johnston; M Plenicar; R W Shaw; J Slack
Journal:  J Psychosom Res       Date:  1988       Impact factor: 3.006

4.  Population screening for cystic fibrosis.

Authors:  D Brock
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

5.  Evaluation of a practice information leaflet.

Authors:  R S Bhopal; W H Gilmour; C W Fallon; J S Bhopal; I Hamilton
Journal:  Fam Pract       Date:  1990-06       Impact factor: 2.267

6.  Patient attitudes to body computed tomography: use of an information leaflet.

Authors:  C R Merrill; A M Knox
Journal:  Clin Radiol       Date:  1986-11       Impact factor: 2.350

7.  The cystic fibrosis gene: medical and social implications for heterozygote detection.

Authors:  B S Wilfond; N Fost
Journal:  JAMA       Date:  1990 May 23-30       Impact factor: 56.272

8.  What participants understand about a maternal serum alpha-fetoprotein screening program.

Authors:  R R Faden; A J Chwalow; E Orel-Crosby; N A Holtzman; G A Chase; C O Leonard
Journal:  Am J Public Health       Date:  1985-12       Impact factor: 9.308

9.  How effective are your patient education materials? Guidelines for developing and evaluating written educational materials.

Authors:  P Farrell-Miller; P Gentry
Journal:  Diabetes Educ       Date:  1989 Sep-Oct       Impact factor: 2.140

10.  Knowledge about and attitudes toward genetic screening among high-school students: the Tay-Sachs experience.

Authors:  C L Clow; C R Scriver
Journal:  Pediatrics       Date:  1977-01       Impact factor: 7.124

View more
  5 in total

1.  Cystic fibrosis carrier population screening in the primary care setting.

Authors:  S Loader; P Caldwell; A Kozyra; J C Levenkron; C D Boehm; H H Kazazian; P T Rowley
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  A comparison of two approaches to education about carrier testing for cystic fibrosis.

Authors:  K P Leonard; L K Bartholomew; P R Swank; G S Parcel
Journal:  J Genet Couns       Date:  1995-06       Impact factor: 2.537

Review 3.  Population screening in cystic fibrosis.

Authors:  J Burn; D Magnay; O Claber; A Curtis
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

4.  Counseling and screening for cystic fibrosis in patients with congenital bilateral absence of the vas deferens: Patient perceptions.

Authors:  J L Fitzpatrick; E M Hutton; R Babul; C S Cytrynbaum; J E Sutherland; C T Shuman
Journal:  J Genet Couns       Date:  1996-03       Impact factor: 2.537

5.  Antenatal screening for cystic fibrosis: a trial of the couple model.

Authors:  J Livingstone; R A Axton; A Gilfillan; M Mennie; M Compton; W A Liston; A A Calder; A J Gordon; D J Brock
Journal:  BMJ       Date:  1994-06-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.